scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Ipca Laboratories Ltd

Feedback
Ipca Laboratories Ltd

Ipca Laboratories Ltd (IPCALAB) Share Price

  • Sector: Pharmaceuticals (Mid Cap)
  • Volume: 133,695
Mar 07, 2025 15:53 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹1,333.10
₹-29.05 (-2.13%)
₹1323.35 Low
Today’s Performance
₹1366 High
₹1052 Low
52 Week’s Performance
₹1755.9 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -2.13%
  • 1 Week -1.64%
  • 1 Month -11.55%
  • 3 Months -12.51%
  • 6 Months -5.03%
  • 1 Year 12.26%
  • 3 Years 11.05%
  • 5 Years 12.75%

Company Stories

Natco Pharma, Orchid Pharma, NBCC India, IPCA Labs: Stock price targets Stock analysts noted Natco Pharma’s missed consensus Q3 estimates on both revenue and Ebitda margin fronts due to lack of Revilimid sales in US and a drop in the domestic formulations business. While API pricing challenges are likely to persist in the near term, Nuvama expects Orchid Pharma to deliver 18 per cent core business growth.

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 1.00
  • Beta 0.44
  • 52-Week Low (₹) 1,052.00
  • 52-Week High (₹) 1,755.90
  • Price-to-Book (X)* 5.04
  • Dividend Yield (%) 0.30
  • Price-to-Earnings (P/E) (X)* 46.28
  • Earnings Per Share (₹) 28.75
  • Sector Price Earning (X)* 32.69
  • Market Cap (₹ Cr.)* 33,821.31
  • * Vaues as of last close price

COMPETITORS

BT TV

BT TV Excl, MCA Secretary On PM Internship Scheme’s Impact 19:41 BT TV Excl, MCA Secretary On PM Internship Scheme’s Impact
Designer Rahul Mishra Decodes The Importance Of Handmade, Heritage-Driven Fashion In AI Era 1:48 Designer Rahul Mishra Decodes The Importance Of Handmade, Heritage-Driven Fashion In AI Era
India Today Conclave: Despite IT Talent, Why Has India Not Created Its Own DeepSeek? 2:36 India Today Conclave: Despite IT Talent, Why Has India Not Created Its Own DeepSeek?
India's Sovereign AI: Why India Must Manufacture Intelligence, Not Just Rely on Global Models! 2:47 India's Sovereign AI: Why India Must Manufacture Intelligence, Not Just Rely On Global Models!
Telangana CM Revanth Reddy: Need A National Consensus To Lower The Fiscal Burden Of Political Sops 4:47 Telangana CM Revanth Reddy: Need A National Consensus To Lower The Fiscal Burden Of Political Sops
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE
Nov 14, 2022 PURCHASE
ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 158841
  • Average Price ₹867.55
Nov 14, 2022 Sell
ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 158841
  • Average Price ₹867.55
Nov 03, 2022 PURCHASE
ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 158842
  • Average Price ₹927.15
Nov 03, 2022 Sell
ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 158842
  • Average Price ₹927.15
Oct 25, 2022 Sell
ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 148105
  • Average Price ₹900.35
Oct 25, 2022 PURCHASE
ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 148105
  • Average Price ₹900.35
Oct 25, 2022 PURCHASE
ISHARES MSCI INDIA SMALL-CAP ETF
  • Qty 68372
  • Average Price ₹900.35
Oct 25, 2022 Sell
ISHARES INDIA SC MAURITIUS COMPANY
  • Qty 68372
  • Average Price ₹900.35
Oct 17, 2022 Sell
ISHARES INDIA SC MAURITIUS COMPANY
  • Qty 34160
  • Average Price ₹889.45
Oct 17, 2022 Sell
ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 232725
  • Average Price ₹889.45
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Dec 18, 2024 Sell
USHA MADHUKAR CHANDURKAR
  • Qty 4000000
  • Average Price ₹1,501.52
Nov 30, 2021 PURCHASE
INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.
  • Qty 2546497
  • Average Price ₹2,103.52
Sep 02, 2021 Sell
GOLDMAN SACHS INDIA FUND LIMITED
  • Qty 927874
  • Average Price ₹2,531.90
Sep 02, 2021 PURCHASE
GOLDMAN SACHS FUNDS GOLDMAN SACHS INDIA EQUITY PORTFOLIO
  • Qty 927874
  • Average Price ₹2,531.90
Nov 27, 2020 PURCHASE
GOLDMAN SACHS INVESTMENTS MAURITIUS I LTD
  • Qty 69473
  • Average Price ₹2,173.10
Nov 27, 2020 PURCHASE
BNP PARIBAS ARBITRAGE
  • Qty 194
  • Average Price ₹2,162.44
Nov 27, 2020 Sell
GOLDMAN SACHS INVESTMENTS MAURITIUS I LTD
  • Qty 675065
  • Average Price ₹2,173.45
Nov 27, 2020 Sell
INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.
  • Qty 2015056
  • Average Price ₹2,158.70
Nov 27, 2020 Sell
BNP PARIBAS ARBITRAGE
  • Qty 1311732
  • Average Price ₹2,154.27
Jun 16, 2017 Sell
AXIS MUTUAL FUND A/C AXIS LONG TERM EQUITY FUND
  • Qty 1108795
  • Average Price ₹453.64
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Ipca Laboratories Ltd share price previously?
Ipca Laboratories Ltd share price was down by -2.13% from the previous closing price of ₹1,362.15.
Who are peers of Ipca Laboratories Ltd?
The peers of Ipca Laboratories Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd,
Who is/are the promoter/promoters of Ipca Laboratories Ltd?
The promotor/promotors of Ipca Laboratories Ltd are Premchand Godha, A K Jain, Pranay Godha, Prashant Godha, Kamal Kishore Seth, Narendra Mairpady, Harish P Kamath, Swati Patankar, Vivek Shiralkar.
What has been 52-week high of Ipca Laboratories Ltd stocks?
The highest price of Ipca Laboratories Ltd stock is ₹1,755.90 in the last 52-week.
What is the share price of Ipca Laboratories Ltd (IPCALAB) today on NSE?
As on Mar 07, 2025, Ipca Laboratories Ltd (IPCALAB)’s share price on NSE is Rs 1333.1
What is the market cap of Ipca Laboratories Ltd (IPCALAB?)
The current market capitalisation of Ipca Laboratories Ltd (IPCALAB) is 33,821.31 crores
What is Ipca Laboratories Ltd Share symbol?
The symbol of Ipca Laboratories Ltd is IPCALAB.
What is the PE ratio of Ipca Laboratories Ltd (IPCALAB)?
The current PE ratio of Ipca Laboratories Ltd (IPCALAB) is 46.28.
What is the PB ratio of Ipca Laboratories Ltd (IPCALAB)?
The current PB ratio of Ipca Laboratories Ltd (IPCALAB) is 5.04.
Today’s High & Low share prices of Ipca Laboratories Ltd (IPCALAB) on NSE?
Today, the share price of Ipca Laboratories Ltd (IPCALAB) on NSE touched a high of Rs 1366 and a low of Rs 1323.35
What price did Ipca Laboratories Ltd (IPCALAB) shares open on the NSE today?
On NSE, the share price of Ipca Laboratories Ltd (IPCALAB) opened at Rs 1362.15
What is the 52-week high of Ipca Laboratories Ltd (IPCALAB)?
The 52-week high price of Ipca Laboratories Ltd (IPCALAB) is Rs 1755.9
What is the 52-week low of Ipca Laboratories Ltd (IPCALAB) ?
The 52-week low price of Ipca Laboratories Ltd (IPCALAB) is Rs 1052

ABOUT IPCA LABS.

Ipca Laboratories Ltd, incorporated in the year 1949, has its registered office in 48 Kandivli Industrial Estate, Kandivli (West), Mumbai, Maharashtra, 400067, 91-22-66474444, 91-22-28686613. The main industry in which Ipca Laboratories Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Ipca Laboratories Ltd is/are Natvarlal Vepari & Co. In the main management, Premchand Godha is chairman and Harish P Kamath is the company secretary for Ipca Laboratories Ltd.

  • PG Premchand Godha Executive Chairman
  • AKJ A K Jain Managing Director & CFO
  • PG Pranay Godha Managing Director & CEO
  • PG Prashant Godha Executive Director
  • KKS Kamal Kishore Seth Independent Non Exe. Director
  • NM Narendra Mairpady Independent Non Exe. Director
  • HPK Harish P Kamath Company Sec. & Compli. Officer
  • SP Swati Patankar Independent Director
  • VS Vivek Shiralkar Independent Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement